In a world defined by constraints, the life science industry faces growing challenges in capacity, efficiency, and partnerships. This webinar explores how Implement Consulting Group and Novo Nordisk enable end-to-end planning and strategic collaboration with external manufacturers to create resilient and scalable operations.

The challenge of operating in a constrained world

Life science companies are facing increasing pressure from global disruptions, regulatory demands, and capacity limitations. Implement Consulting Group outlines six OPEX domains driving transformation, from digital technologies and sustainability to site efficiency and partnerships. Understanding and managing constraints through end-to-end visibility has become essential for maintaining competitiveness and resilience.

Enabling end-to-end planning and execution

Experts from Implement highlight that successful transformation requires vertical and horizontal integration across the supply chain. They emphasize five key enablers: full value chain focus, transparency, business rules, standardized systems, and strong master data. Together, these enable proactive, integrated decision-making and a shift from reactive “acoustic planning” to data-driven input planning aligned with company priorities.

Building strategic partnerships with CDMOs

As pharmaceutical companies expand, partnerships with contract manufacturers are becoming vital. Novo Nordisk shares how segmentation and structured collaboration drive performance and efficiency. Implement’s viewpoint adds a practical framework for segmenting CDMOs by criticality and performance to optimize resources, enhance communication, and identify new partnership opportunities that strengthen long-term value creation.